Hem › Bukspottkörtelcancer › Virginia › Arlington
Kliniska studier för Bukspottkörtelcancer i Arlington, VA
33 studier för Bukspottkörtelcancer söker deltagare vid platser i och runt Arlington (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekryterarFriska volontärer välkomna
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
- Inova Fair Oaks Hospital, Fairfax · 11 mi bort
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RekryterarFas 3
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
A Study of PHN-012 in Patients With Advanced Solid Tumors
RekryterarFas 1
- PHN-012-001 Site, Fairfax · 11 mi bort
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekryterarFas 1
- NEXT Oncology Virginia, Fairfax · 11 mi bort
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RekryterarFas 3
- Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekryterarFas 3
- Investigative Site US057, Fairfax · 11 mi bort
- Investigative Site US065, Fairfax · 11 mi bort
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RekryterarFas 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi bort
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekryterarFas 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi bort
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekryterarFas 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 mi bort
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RekryterarFas 1
- NEXT - Virginia, Fairfax · 11 mi bort
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RekryterarFas 1
- NEXT Oncology, Fairfax · 11 mi bort
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekryterarObservationsstudie
- Inova Fairfax Hospital, Falls Church · 4 mi bort
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
- Inova Fair Oaks Hospital, Fairfax · 11 mi bort
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RekryterarFas 2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RekryterarFas 1
- Virginia Cancer Specialists, PC, Fairfax · 11 mi bort
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekryterarFas 3
- Inova Fairfax Hospital, Falls Church · 4 mi bort
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
- Inova Fair Oaks Hospital, Fairfax · 11 mi bort
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RekryterarFas 1
- NEXT Virginia, Fairfax · 11 mi bort
Pancreatic Cancer Early Detection Consortium
RekryterarObservationsstudieFriska volontärer välkomna
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
RekryterarFas 1
- NEXT Virginia, Fairfax · 11 mi bort
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekryterarFas 1
- NEXT Virginia, Fairfax · 11 mi bort
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RekryterarFas 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · 11 mi bort
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RekryterarFas 1
- Research Site, Fairfax · 11 mi bort
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekryterarFas 1
- NEXT Oncology Virginia, Fairfax · 11 mi bort
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RekryterarFas 3
- Inova Schar Cancer Institute, Fairfax · 11 mi bort
- Inova Fair Oaks Hospital, Fairfax · 11 mi bort
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekryterarFas 1/2
- Next Oncology Virginia, Fairfax · 11 mi bort
A 2-part Phase 1/2 Open-label Trial on ODM-212
RekryterarFas 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi bort
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RekryterarFas 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi bort
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekryterarFas 1/2
- NEXT Virginia, Fairfax · 11 mi bort
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RekryterarFas 1/2
- NEXT, Virginia, Fairfax · 11 mi bort
Bukspottkörtelcancer-studier i andra städer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
- San Diego, CA24 studier
Andra studier i Arlington
- Icke-småcellig lungcancer104 studier
- Metastaserande cancer53 studier
- Kolorektal cancer52 studier
- Cancer (alla typer)48 studier
- Bröstcancer47 studier
- Äggstockscancer46 studier
- Lungcancer41 studier
- Endometriecancer39 studier
- Plattenepitelcancer i huvud och hals26 studier
- Småcellig lungcancer23 studier
- Magsäckscancer20 studier
- Triplenegativ bröstcancer20 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.